AzTrials
AzTrials

FibromyalgiaFMostéoNCT02805673

Osteopathic Support Evaluation of Fibromyalgia Patients

A study testing Osteopathy in people with Fibromyalgia, run by University Hospital, Caen at 1 site in France.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

At present, the literature does not account for much of scientific data on the assessment of osteopathic intervention for patients with (Fibromyalgia) FM. The investigators propose a pilot study evaluating the efficacy of osteopathic care, consists of several osteopathic interventions in the treatment of FM, in order… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Fibromyalgia
What is being tested?
Osteopathy
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
32 participants
Where
1 siteFrance
Study dates
22 Apr 2015to 17 Dec 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • FM patient diagnosed according to the ACR criteria.
  • Patient Having realized biological balances excluding any underlying pathology that may be causing the pain.
  • Patient Over 18 years followed at Caen University Hospital.
  • Patient Treated with drugs to its FM.
  • Patient Being informed and having signed his consent.
  • Patient Affiliated to the social security system.
  • French-Patient.

Who cannot join

  • FM undiagnosed according to the ACR criteria.
  • Patient Showing against -indications to the osteopathic surgery.
  • Patient Treated by manual therapy ( physiotherapy, osteopathy, acupuncture... ) during the trial and during the three months preceding the study.
  • Concomitant Maladie (type cancers, cardiovascular diseases, rheumatic diseases ) or all diseases causing bone pain and myalgia.
  • Important Surgery of less than 3 months.
  • Inability to submit to medical monitoring study for geographical or social reasons.
  • Inclusion The subject in another biomedical research protocol for this study.
  • Women Pregnant or nursing.

Trial locations and contacts

1 site in 1 country.

France1 site
  • CHU Caen

    Caen, 14000

Other trials in France

About this study

At present, the literature does not account for much of scientific data on the assessment of osteopathic intervention for patients with (Fibromyalgia) FM. The investigators propose a pilot study evaluating the efficacy of osteopathic care, consists of several osteopathic interventions in the treatment of FM, in order to improve the painful experiences of FM patients. This study must include 44 patients with FM according to (American College of Rheumatology) ACR criteria and followed the University Hospital of Caen.

The osteopathic care will last eight months and will be followed by a report three months after the end of osteopathic interventions. This in order to evaluate the effect in the short term and long term, of osteopathic care in patients with FM.

Conditions
Fibromyalgia
Being tested
Osteopathy
Keywords
Osteopathy, Support, Treatment, Pain, Quality of Life
Medical subject headings
Fibromyalgia, Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • OsteopathyProcedure or surgery

Study groups in NCT02805673
Study groupRoleWhat they receive
OSTEO groupExperimentalusual medical treatment + 6 osteopathic interventions
Receives: Procedure: Osteopathy
witness groupNo interventionusual medical treatment

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Visual Analogue Scale for pain

    Measured: chenge between Day 232 - Day 0

Secondary outcomes (4)
  1. Visual Analogue Scale for pain

    Measured: change after Week 6, Week 12, Week 18, Week 24, Week 32, Week 38 and day 301, compared to day 0

  2. QDSA score

    Measured: at day 232 until day 301 and compared to day 0

  3. SF-36 score

    Measured: at day 232 until day 301 and compared to day 0

  4. number of tender points

    Measured: at day 232 to day 301 and compared to day 0

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Jun 2016 (estimated)
  2. Study start22 Apr 2015
  3. Primary completion17 Dec 2018
  4. Study completion17 Dec 2019

Why it stopped: lack of patient

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
32 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02805673
Sponsor's protocol ID
2014-A00687-40
Acronym
FMostéo
Status last verified
Jan 2020
First submitted
18 Jan 2016
Last updated
26 Jun 2026
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing Osteopathy in people with Fibromyalgia, run by University Hospital, Caen at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 26 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was stopped early (reason given: lack of patient). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Visual Analogue Scale for pain (time frame: chenge between Day 232 - Day 0). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Jun 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in